This webinar focuses on manufacturing aspects that enable successful development and scale-up of the micronization process. Technical issues that must be investigated for successful development of effective API micronization will be explored. An overview of micronization and typical scale-up challenges will be presented along with a robust process development strategy to ensure critical-to-quality attributes are maintained. Register Now.
The road to IND isn’t always easy. Balancing speed, risk, and future needs is a challenge. Join Paul Jorjorian, Vice President and General Manager, Thermo Fisher Scientific, and learn how you can take your molecule from discovery to FiH trials without undue risk or excessive timelines. Plus, find out how you can meet short-term goals while preparing for future commercialization success. Register Now.
Learn how a small, investigator-initiated project developed into a valuable COVID-19 chest CT dataset using Flywheel's research data management platform. You will also hear how Imbio is exploring the correlation between lung injury severity and patient prognosis, as well as developing AI to diagnose COVID-19. Digital transformation professionals, radiologists, data scientists, and clinical and translational imaging leads should attend to learn about integrating radiology research and AI solutions to enable collaboration and improve R&D efficiency. Register now.
Biopharmaceutical drug pricing and market access contracting have become more complicated and interrelated than ever. Join us to discuss how a more integrated, intuitive approach to pricing and contracting can create organizational agility. Discover how this inter-connected approach can have a radical impact on the profitability of life sciences organizations as well as align incentives across the health care ecosystems. Register now.
HitGen has established an industry-leading drug discovery platform for small molecules and nucleic acid drugs centered on the design, synthesis and screening of DNA encoded chemical libraries (DELs), fragment-based drug discovery (FBDD) and structure-based drug design (SBDD) technologies. HitGen founder Dr. Jin Li and Vernalis chief scientist Professor Rod Hubbard will join hands to illustrate advancing innovative drug discovery by DNA Encoded Library and FBDD/SBDD methods. Register Now.
In this webinar hear from “both sides of the house” – first from an innovative information technology leader and then a senior scientist who uses the solutions provided by IT. Learn how MOMA Therapeutics’ innovative lead discovery solution can be applied to the needs of your biotechnology discovery workflows. Save Your Spot.
Real-world data are currently supporting decision making across the spectrum of oncology care. Join us as we discuss the current paradigm of oncology product development life cycle and the use of real-world oncology data to drive innovation, efficiencies, and improvements in patient outcomes. Register now.
In today’s complex market, emerging and mid-size pharmaceutical manufacturers require the expertise and supporting technologies, across multiple disciplines, to effectively maximize product revenue and optimize market access functions. Join us on July 22, as industry expert, Tracy Mumpower, shares strategies for integrating a Business Service operations model with your Commercial and Market Access teams, to continue to drive operational excellence and insights through the power of People, Process, and Technology. Register Now.
In November, clinical trial platform developer Medable raised $91 million in private funding, amid the COVID-19 pandemic that touched off huge demand among pharmaceutical companies looking to initiate “siteless” or virtual clinical trials. This webinar will explore the role of CROs in siteless trials and the opportunities and challenges for CROs to expand their capabilities in this burgeoning area. Register now.
In this webinar, we will establish the medical backdrop for COVID-19 virus sequencing in drug development, connect insights from population surveillance to potential solutions for drug developers, describe the biological relevance of sequencing in drug development, and outline approaches to COVID-19 virus sequencing, including the application of both targeted and whole genome sequencing to drug development. Register now!
Life Sciences manufacturers that focus on streamlining the tendering and bidding process win more. Join our tender experts for a virtual session to learn strategies to optimize your bids, streamline processes, and improve collaboration and visibility across the tender lifecycle. You’ll also hear from Veronica Gil, Pricing & Tender Director, Baxter EMEA, on how her team leveraged technology to centralize processes and develop a winning tender strategy. Register Now.
Nearly a quarter of adults worldwide are thought to have non-alcoholic fatty liver disease; between 11% and 40% of them will progress to non-alcoholic steatohepatitis (NASH). Join industry leaders for a webinar dedicated to overcoming key challenges presented in NASH drug development. We’ll explore key considerations for liver biopsy collection and interpretation, emerging non-invasive biomarkers, and the connection between clinical practice and drug development. Register now.
Join this webinar to hear experts share how dissolution tools and PBPK modeling can help evaluate whether a molecule is suitable for controlled release applications and predict the effects of release rate on in vitro performance. In addition, the experts will cover all aspects of oral controlled release technologies and discuss current strategies to select the optimal technology to meet the intended release profile. Register Now.
Healthcare is becoming more virtual and digital healthcare tools more common, which presents new challenges and opportunities for pharma sales. In response, brands are turning to innovative digital solutions to enhance and augment sales, including intelligent bots powered by conversational AI that can automate and augment HCP education and support. In this session, you’ll hear from leading agency experts working to transform HCP experiences with conversational AI voice and chatbots. Register Now.
Optimizing the manufacture and delivery of significant amounts of therapeutically potent cells, extend today’s frontiers in the field of cell therapy and regenerative medicine. Leaders in the pharma and biotech industry, health care sector and life science researchers will get insights about the latest advances in regenerative medicine, gene editing platforms, tackling the critical limitations in developing CRISPR therapeutics and more. Register Today.
Before COVID-19, the typical vaccine took more than five years to develop. Biopharma companies raced from virus discovery to phase 3 testing of their COVID-19 vaccines in under a year. Now the industry is asking an important question: Can we take what we learned from COVID-19 vaccine successes and use it to speed up the development of other vaccines? Register now.
Large or small, cyberattacks are making headlines and elevating executive attention toward cyber resiliency. During this session, we will explore security considerations for developing cyber resilience covering security fundamentals and readiness planning to protect your IT and OT environments. Register now.
The recently heightened awareness of racial discrimination coupled with COVID-19’s disproportionate toll on disadvantaged communities has spurred the need for change. Yet the lack of equity and representation of minority groups in clinical research has been an open concern for decades. Attendees will learn how to optimize patient diversity and inclusivity of clinical trials. Register Now.
As we head into ASCO weekend, cancer experts will highlight closely watched data sets to be unveiled at the meeting. This discussion will take a close look at oncology's hottest fields, including CAR-T and precision medicine, as panelists zero in on the conference's most highly anticipated studies, 2021's biggest research trends, and the data they're most looking forward to seeing. Register now.
Learn how human pluripotent stem cells (hPSCs) are being manufactured at scale for clinical applications under current Good Manufacturing Practices (cGMPs) from Dr. Dhruv Sareen, the Executive Director of the Cedars-Sinai Biomanufacturing Center. Register Now.
When patients self-administer their medications, 60% do not take them as intended and over half of all patients are non-adherent. The resulting cost of non-adherence and non-optimized therapy is steep and everyone pays the price. The rules around healthcare engagement are now being rewritten, and technology has the potential to augment patient care, deliver value across the digital health ecosystem, and deliver better outcomes for all stakeholders in a more connected future. Register now.
FDA is opening up to data gathered outside the hermetically sealed clinical trial setting as regulators recognize the need for a more flexible framework for evaluating treatments. As a new approach that requires significant investment, RWE use requires the right talent and technology. Where to find those resources and how to deploy them are some of the questions companies face. We’ll address these questions and more with the help of current practitioners in the field. Register now.
Learn how Philips and QIAGEN are using mRNA technology in OncoSignal tests to quantify functional activity of disease-relevant signal transduction pathways in any cell and tissue type. This webinar will explore applications for both preclinical disease modeling and clinical measurement of response to targeted therapies and immunotherapies. Register now.
Interested in digitizing your R&D organization, but not sure where to start? Looking to move from a wealth of spreadsheets and outdated software systems into one centralized data repository? This webinar shows what a modern software system should look like for R&D and how that compares to how most companies operate today. Register Today!
UNITY Biotechnology partnered with Rho to execute a complex and fast-moving Osteoarthritis program with three concurrent clinical trials and database locks scheduled during the height of the COVID-19 pandemic. In this webinar, hear from both the Sponsor and CRO about the creative solutions they implemented and how they worked together to pivot quickly and meet critical study timelines in the midst of the pandemic. Register Now.
The field of oncology biomarker testing is growing rapidly. With so many new cancer treatments available requiring specific biomarkers for prescription, oncologists have plenty of new information to follow and many decisions to make when treating individual tumors. Register now.
Learn actionable and real-world recommendations from Honeywell’s experienced ICS/OT cybersecurity team, as they reveal how they’ve coached both sites and enterprises to establish a resilient ICS/OT cybersecurity program. Register Now!
Life science technology leaders will discuss how Apprentice.io’s pharma-compliant remote collaboration platform helped them steady supply chains, better manage operations, and increase speed to market during the pandemic. Hear about how the adoption of this platform helped their teams successfully navigate manufacturing challenges and ultimately deliver safer, more reliable drug products, treatments and therapies – from COVID to cancer. Register now.
Learn how Eli Lily put the power of text mining in the hands of primary (non-data-scientist) users through Linguamatics Web Portals. With the on-going information explosion, natural language processing (NLP)-based text mining has become important to gain meaning effectively from unstructured text. Register now.
Learn how Prognos Health and Datavant are transforming & improving the way life sciences can access an extensive network of integrated real world data sources to define an ideal patient cohort as well as key demographic, therapeutic & customer insights. Register now.
This Fierce webinar will feature executives from leading biopharma companies and technology-development firms, who will describe the latest tools and techniques for improving biomarker discovery. They will discuss how they chose and deployed these technologies, provide examples of how they led to the discovery of novel biomarkers, and offer tips for selecting tools to aid in biomarker discovery and incorporating them into established R&D processes. Register Today!
Biotechnology companies of all sizes face many challenges in the development of new cell and gene therapies. In this webinar, Mike O’Mara and Dr. Ian Gaudet will introduce the development and manufacturing approach used by Miltenyi Biotec and describe how a CDMO partner focused in process and analytical development can enable clinical readiness. Register Now.
In 2020, consumers purchased over-the-counter (OTC) medicine heavily in March, but then shifted their consumption to vitamins and dietary supplements (VMS) for the remainder of the year. In this webinar, Catalent partnered with NielsenIQ to bring forward new insights that provide starting points for re-establishing growth via innovation in the OTC market. Save Your Spot - Register Now.
Attend this webinar to learn about the role neutralising antibody testing plays in antibody detection, response to mass vaccination, longevity of immunity to SARS-CoV-2, and examine performance characteristics data. Register now.
COVID-19 has resulted in delayed care across specialties. Join us as we discuss returning to pre-pandemic clinical activity and strategies that biopharma organizations are using to engage HCPs. Register now.
Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM, a rare, life-threatening neuromuscular disease, affecting about 1 in 40-50,000 newborn males. The session will review how IPM.ia and Audentes collaborated to uncover the XLMTM patient population. Register now.
March Is Multiple Myeloma Month. In recognition of this important month, join us for a Precision Key Opinion Leader (KOL) Insights series webinar. You’ll hear from two leading investigators on the lessons learned, current trends, and insights relevant to the Multiple Myeloma (MM) US and EU research community. Dr. Paul Richardson and Dr. Maria-Victoria Mateos have collectively published >700 papers and both have been recognized for excellence in MM research. This is a rare opportunity to get a look into current MM treatment. Register Now.
Cell, gene-modified cell and gene therapies hold the promise to offer new hope and novel therapeutic avenues for individuals facing serious illnesses and medical conditions. But bringing these therapies successfully through the clinical trial process introduces a level of supply chain risk, complexity and specialized requirements which are not yet fully understood. This webinar focuses on taking a closer look at unique clinical supply challenges and unique needs associated with cell and gene therapies. Register Now.
Scaling up research procedures into clinical-scale manufacturing of new cellular therapeutics presents a challenge for many academic facilities. Join Drs. Adrian Gee and David McKenna in this live webinar for a discussion about the issues to be addressed when translating your cell and gene therapy research to the clinic; from picking your team to finding an effective culture system and beyond. Register Now.
The FDA has hired more than 50 new reviewers in anticipation of receiving 200 applications per year from companies hoping to start clinical trials of gene and cell therapies and issuing 10 to 20 new approvals a year by 2025. This webinar will review the latest developments in the regulatory review process for gene and cell therapies, offering advice that companies can use to streamline their interactions with regulators, both in the U.S. and overseas. Register Now.
In this webinar, a panel of experts -- representing patient advocacy, cardiology, pharmaceutical, and health technology -- will discuss approaches for empowering individuals with heart conditions to act on best insights tailored to their specific situation (in a permissioned manner). Register Now.
Leaders discuss how Data Science as a Service (DSaaS) can empower life sciences organizations to tackle critical healthcare issues. Register now.
Pharmaceutical companies face numerous hurdles during early development, from API manufacturing to drug product formulation to clinical supply logistics. Join Thermo Fisher Scientific experts to learn how a simplified supply chain may help increase efficiency and reduce risk as you move to your Phase I milestone. Register Now.
The US FDA’s Breakthrough Therapy Designation, Regenerative Medicine Advanced Therapy Designation, Accelerated Approval Program, Priority Review, and Fast Track Designation can reduce your product’s development and approval timelines if pursued at the optimal time and implemented appropriately. Successfully navigate US FDA’s expedited programs for development of products for serious conditions: Understand the data expectations, planning and timing skills, and authoring strategies to optimize the chance of securing an expedited program designation. Register Now.
Cell and gene therapies are placing the patient at the center of the supply chain in a vastly new way, with implications for production, financial operations, product ordering, logistics and patient access and support. With these high-value therapies gaining more acclaim and moving from academic treatment centers to community care, their therapeutic and commercial success will be more highly scrutinized. Register Now!
Join LabCorp and Nutanix for this one-hour webinar to learn how cloud infrastructure technology platform is transforming the business. You will learn how a design partnership between LabCorp and Nutanix can have a long-lasting positive impact in elevating the role of IT teams to become the strategic business partners for the organization.
This webinar will focus on how a pharmacist-led clinical trial model impacts the six key areas most relevant to clinical trials in today’s COVID and Decentralized Clinical Trial environment: regulations, recruiting, diversity, clinical outcomes, data integrity, and clinical supply chain. Register Now.
Are you looking for a higher-quality, faster-time to market manufacturing solution for your protein therapeutic? Webinar attendees will learn how AbSci and KBI’s partnership enables cell line development through bulk microbial GMP manufacturing in 6 months, using cutting edge cell line development and biomanufacturing technology. Register Now.
Every year we ask our physicians their views on the future of the healthcare industry. With so much disruption from COVID-19, this year’s global insights will provide a unique window into the minds of those professionals perhaps most tested by 2020 and their hopes and perspectives for 2021. Register Now!
The transition from early phase to late phase of a small molecule program plays a pivotal role in determining a program’s ultimate success. Join this webinar to hear experts discuss the key considerations for tech transfer and present how a customized modeling tool can help streamline the scale-up of your oral small molecule program. Register Now.
Along with the complexities of vaccine and viral-based gene therapy process development comes the need for analytical techniques that can help assess quality parameters, especially in real-time. Join Catalent and LumaCyte to learn how label-free analysis can provide near real-time infectivity measurements for vaccines and viral-based gene therapies. Register Today.
The covid vaccine launch has created a vast amount of calls to healthcare organizations. To keep up, you need a solution that can be stood up in less than 30 days. Join NeuraFlash & Salesforce as we showcase how to get started today! Register now.
During this webinar, attendees will learn about Thermo Fisher Scientific’s new 5KL bioreactor and how it benefits clients who outsource late-phase biologics drug substance manufacturing. An introduction of the 5KL bioreactor will be provided, as well as application data around performance and scalability, process economy comparison with traditional stainless steel bioreactors, and decision criteria that could be helpful in choosing between different cell culture strategies. Register Today.
AbSci’s Protein PrintingTM technology enables rapid E. coli SoluPro® cell line development for complex therapeutic proteins. We will detail our ability to go from gene to purified antibody in 10 days, including cell line construction, fermentation, purification, and protein characterization. Register Today!
InCrowd’s Care, Compliance, and Compromise—Adherence in the COVID Era webinar examines the challenges facing healthcare professionals (HCPs) and patients during COVID-19 as they try to ensure adherence, while limiting exposure. The research analyzes insights shared by oncologists, rheumatologists, endocrinologists, and dermatologists, among others. Register Now.
Interested in complete supply chain real-time data visibility? Unlock productivity with digital workflows, manage plants inventory with real-time supply chain information and enable faster decision-making with data visualization with pci | bridge. Save your spot.
During this webinar, hear from Kalderos to learn:
- An overview of compliance and operational challenges facing the 340B program
- Why 340B rebates can eliminate duplicate discounts
- How covered entities, manufacturers, state Medicaid programs and other stakeholders will benefit from 340B rebates